Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) does about 954.77K shares in volume on a normal day but saw 1273346 shares change hands in the recent trading day. The company now has a market cap of 12.05B USD. Its current market price is $14.46, marking an increase of 0.42% compared to the previous close of $14.40. The 52 week high reached by this stock is $16.89 whilst the lowest price level in 52 weeks is $13.26.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) has a 20-day trading average at $14.29 and the current price is -14.40% off the 52-week high compared with 9.02% distance from its 52-week low. The 50-day simple moving average of the closing price is $14.91 and its 200-day simple moving average is $15.12. If we look at the stock’s price movements over the week, volatility stands at 1.11%, which increases to 1.37% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 48.23 to suggest the stock is neutral.
The consensus objective for the share price is $16.16, suggesting that the stock has a potential upside of 10.52% over the period.
The current price level is 1.21%, -3.02%, and -4.39% away from its SMA20, SMA50, and SMA200 respectively, with the RDY price moving above the 50-day SMA on current market day. Dr. Reddy’s Laboratories Ltd. ADR (RDY) stock is down -0.75% over the week and -0.69% over the past month. Its price is 3.91% year-to-date and 7.43% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 16.15 and 74.65 for whole year. Expected sales for next quarter are $82.56B, which analysts say will come at $320.98B for the current fiscal year and next year at $346.57B. In addition, estimates put the company’s current quarterly revenue at an average of $82.69B.
To reach the target analysts have set, the stock logically needs to grow 10.52 percent from here.
The company has a return on investment of 17.14% and return on equity of 19.12%. The price to earnings ratio (P/E ratio) amounts to 18.85 while the forward price to earnings ratio is 17.75. The beta has a value of 0.53. Price to book ratio is 3.31 and price to sales ratio is 3.35.
